Prosecution Insights
Prosecution Insights
Listed by the USPTO as SWARTWOUT, BRIANNA KENDALL
Tech Center 1600 • Art Units: 1644
This examiner grants 45% of resolved cases
Brianna Kendall Swartwout is an examiner in Tech Center 1600 and Art Unit 1644. She has 62 resolved cases with an allowance rate of 45.2 percent. A significant statistic is the 61.3 percent interview lift. This suggests that examiner interviews provide an increase in the likelihood of an allowance. The median time to reach an allowance is 1319 days.
Her top company is The Board of Trustees of the Leland Stanford Junior University. The 45.2 percent allowance rate across 62 cases indicates the environment in her docket, but the 61.3 percent interview lift offers a path for overcoming rejections. This lift is an impactful metric in her docket for practitioners to consider.
Given the 1319-day median pendency, applicants should be prepared for the prosecution duration. However, the interview lift suggests that direct dialogue should be a strategy. With 62 resolved cases, the examiner's data highlights the importance of engagement in Art Unit 1644 to improve the chances of a grant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17904562 | ANTIBODY FRAGMENTS CONJUGATED TO PEG-PLGA NANOPARTICLES IMPROVE IMMUNOTHERAPY AGAINST CANCER CELLS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy45.2% of resolved applications examined by Brianna Kendall Swartwout were allowed (62 resolved cases), compared with 35.9% across Art Unit 1644 over the last five years.
This examiner's interview lift is +61.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Brianna Kendall Swartwout took 1,319 days on average from filing to allowance.
Brianna Kendall Swartwout examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).